邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

乳腺癌影像组学研究进展

罗焱文,  朱庆莉

downloadPDF
文章导航 > 协和医学杂志  > 2021 >  12(6): 983-988
罗焱文, 朱庆莉. 乳腺癌影像组学研究进展[J]. 协和医学杂志, 2021, 12(6): 983-988. doi: 10.12290/xhyxzz.2021-0011
引用本文: 罗焱文, 朱庆莉. 乳腺癌影像组学研究进展[J]. 协和医学杂志, 2021, 12(6): 983-988. doi: 10.12290/xhyxzz.2021-0011
shu
LUO Yanwen, ZHU Qingli. Application of Radiomics in Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 983-988. doi: 10.12290/xhyxzz.2021-0011
Citation: LUO Yanwen, ZHU Qingli. Application of Radiomics in Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 983-988. doi: 10.12290/xhyxzz.2021-0011
shu

乳腺癌影像组学研究进展

doi: 10.12290/xhyxzz.2021-0011

  • 中国医学科学院 北京协和医学院 北京协和医院超声医学科，北京 100730

基金项目: 

国家自然科学基金 81771855

中国医学科学院医学与健康科技创新工程项目 2020-I2M-C&T-B-033

详细信息
    通讯作者:

    朱庆莉  电话：010-69155494，E-mail：zqlpumch@126.com

  • 中图分类号: R445.1;R737.9

Application of Radiomics in Breast Cancer

  • Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National Natural Science Foundation of China 81771855

CAMS Innovation Fund for Medical Science 2020-I2M-C&T-B-033

More Information
    Corresponding author: ZHU Qingli  Tel: 86-10-69155494, E-mail: zqlpumch@126.com

    摘要
  • 摘要: 乳腺癌是我国女性最常见的恶性肿瘤，如何更好地对其进行早期诊断、治疗和预后评估是临床亟待解决的问题。影像组学以非侵入性方式高通量提取并分析病灶的图像特征，可提供更多潜在的肿瘤信息，进而指导临床进行精准诊疗。近年来，影像组学在乳腺癌领域的研究被广泛关注，涉及乳腺癌患者全程管理的各个环节，诊断方面研究已趋于成熟，逐步进入临床转化阶段，疗效评估和预后预测尽管尚处于初步探索阶段，但具有广阔的发展前景。本文从诊断、疗效评估和预后预测三个方面进行综述，以期为临床诊疗提供借鉴。
    Abstract: Breast cancer is the most common malignant tumor in Chinese women. Early diagnosis, treatment, and prognosis assessment are important clinical problems to be solved. Radiomics is a non-invasive method for high-throughput extraction and analysis of lesion features of images to provide more potential information of tumors, and guide precise diagnosis and treatment. Recently, it has been widely concerned and studied in breast cancer, covering every stage in the care of patients with breast cancer. In terms of diagnosis, the research has reached the level of maturity and gradually proceeded to the clinical setting. Regarding efficacy evaluation and prognostic prediction, although in its infancy, radiomics shows promising potential. This paper mainly reviews the application of radiomics in the diagnosis, response evaluation, and prognosis prediction of breast cancer.
    作者贡献：罗焱文负责文献收集、论文撰写及校对; 朱庆莉负责论文选题构思和修订。
    利益冲突：无
    • HTML全文
    • 参考文献(47)
  • [1] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66: 115-132. doi:  10.3322/caac.21338
    [2] Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48: 441-446. doi:  10.1016/j.ejca.2011.11.036
    [3] Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data[J]. Radiology, 2016, 278: 563-577. doi:  10.1148/radiol.2015151169
    [4] Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art[J]. Radiology, 2013, 268: 642-659. doi:  10.1148/radiol.13121606
    [5] Chitalia RD, Kontos D. Role of texture analysis in breast MRI as a cancer biomarker: A review[J]. J Magn Reson Imaging, 2019, 49: 927-938. doi:  10.1002/jmri.26556
    [6] Jiang Y, Edwards AV, Newstead GM. Artificial Intelli-gence Applied to Breast MRI for Improved Diagnosis[J]. Radiology, 2021, 298: 38-46. doi:  10.1148/radiol.2020200292
    [7] Li J, Sang T, Yu WH, et al. The value of S-Detect for the differential diagnosis of breast masses on ultrasound: a systematic review and pooled meta-analysis[J]. Med Ultrason, 2020, 22: 211-219. doi:  10.11152/mu-2402
    [8] Mao N, Yin P, Wang Q, et al. Added Value of Radiomics on Mammography for Breast Cancer Diagnosis: A Feasibility Study[J]. J Am Coll Radiol, 2019, 16: 485-491. doi:  10.1016/j.jacr.2018.09.041
    [9] McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening[J]. Nature, 2020, 577: 89-94. doi:  10.1038/s41586-019-1799-6
    [10] Li H, Mendel KR, Lan L, et al. Digital Mammography in Breast Cancer: Additive Value of Radiomics of Breast Parenchyma[J]. Radiology, 2019, 291: 15-20. doi:  10.1148/radiol.2019181113
    [11] Zhou J, Zhang Y, Chang KT, et al. Diagnosis of Benign and Malignant Breast Lesions on DCE-MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue[J]. J Magn Reson Imaging, 2020, 51: 798-809. doi:  10.1002/jmri.26981
    [12] Lee SE, Han K, Kwak JY, et al. Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma[J]. Sci Rep, 2018, 8: 13546. doi:  10.1038/s41598-018-31906-4
    [13] Luo WQ, Huang QX, Huang XW, et al. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS[J]. Sci Rep, 2019, 9: 11921. doi:  10.1038/s41598-019-48488-4
    [14] Hao W, Gong J, Wang S, et al. Application of MRI Radiomics-Based Machine Learning Model to Improve Contralateral BI-RADS 4 Lesion Assessment[J]. Front Oncol, 2020, 10: 531476. doi:  10.3389/fonc.2020.531476
    [15] Zhang X, Liang M, Yang Z, et al. Deep Learning-Based Radiomics of B-Mode Ultrasonography and Shear-Wave Elastography: Improved Performance in Breast Mass Classifica-tion[J]. Front Oncol, 2020, 10: 1621. doi:  10.3389/fonc.2020.01621
    [16] Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial[J]. Ann Surg Oncol, 2006, 13: 491-500. doi:  10.1245/ASO.2006.05.013
    [17] Hindié E, Groheux D, Brenot-Rossi I, et al. The sentinel node procedure in breast cancer: nuclear medicine as the starting point[J]. J Nucl Med, 2011, 52: 405-414. doi:  10.2967/jnumed.110.081711
    [18] Cui X, Wang N, Zhao Y, et al. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer using Radiomics Features of DCE-MRI[J]. Sci Rep, 2019, 9: 2240. doi:  10.1038/s41598-019-38502-0
    [19] Liu J, Sun D, Chen L, et al. Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer[J]. Front Oncol, 2019, 9: 980. doi:  10.3389/fonc.2019.00980
    [20] Schiano C, Franzese M, Pane K, et al. Hybrid (18)F-FDG-PET/MRI Measurement of Standardized Uptake Value Coupled with Yin Yang 1 Signature in Metastatic Breast Cancer. A Preliminary Study[J]. Cancers (Basel), 2019, 11: 1444. doi:  10.3390/cancers11101444
    [21] Yang J, Wang T, Yang L, et al. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Mammography-Based Radiomics Method[J]. Sci Rep, 2019, 9: 4429. doi:  10.1038/s41598-019-40831-z
    [22] Mao N, Yin P, Li Q, et al. Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study[J]. Eur Radiol, 2020, 30: 6732-6739. doi:  10.1007/s00330-020-07016-z
    [23] Giuliano AE, Ballman KV, McCall L, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial[J]. JAMA, 2017, 318: 918-926. doi:  10.1001/jama.2017.11470
    [24] Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer[J]. Nat Commun, 2020, 11: 1236. doi:  10.1038/s41467-020-15027-z
    [25] Gao Y, Luo Y, Zhao C, et al. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients[J]. Eur Radiol, 2021, 31: 928-937. doi:  10.1007/s00330-020-07181-1
    [26] Guo X, Liu Z, Sun C, et al. Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer[J]. EBioMedicine, 2020, 60: 103018. doi:  10.1016/j.ebiom.2020.103018
    [27] Liu C, Ding J, Spuhler K, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI[J]. J Magn Reson Imaging, 2019, 49: 131-140. doi:  10.1002/jmri.26224
    [28] Goetz MP, Gradishar WJ, Anderson BO, et al. NCCN Guidelines Insights: Breast Cancer, Version 3.2018[J]. J Natl Compr Canc Netw, 2019, 17: 118-126. doi:  10.6004/jnccn.2019.0009
    [29] Li P, Wang X, Xu C, et al. (18)F-FDG PET/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients[J]. Eur J Nucl Med Mol Imaging, 2020, 47: 1116-1126. doi:  10.1007/s00259-020-04684-3
    [30] Chen S, Shu Z, Li Y, et al. Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients[J]. Front Oncol, 2020, 10: 1410. doi:  10.3389/fonc.2020.01410
    [31] Liu Z, Li Z, Qu J, et al. Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study[J]. Clin Cancer Res, 2019, 25: 3538-3547. doi:  10.1158/1078-0432.CCR-18-3190
    [32] Antunovic L, De Sanctis R, Cozzi L, et al. PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy[J]. Eur J Nucl Med Mol Imaging, 2019, 46: 1468-1477. doi:  10.1007/s00259-019-04313-8
    [33] Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI[J]. Breast Cancer Res, 2017, 19: 57. doi:  10.1186/s13058-017-0846-1
    [34] Sutton EJ, Onishi N, Fehr DA, et al. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy[J]. Breast Cancer Res, 2020, 22: 57. doi:  10.1186/s13058-020-01291-w
    [35] Bitencourt AGV, Gibbs P, Rossi Saccarelli C, et al. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer[J]. EBioMedicine, 2020, 61: 103042. doi:  10.1016/j.ebiom.2020.103042
    [36] Moscoso A, Ruibal A, Dominguez-Prado I, et al. Texture analysis of high-resolution dedicated breast (18) F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer[J]. Eur J Nucl Med Mol Imaging, 2018, 45: 196-206. doi:  10.1007/s00259-017-3830-1
    [37] Antunovic L, Gallivanone F, Sollini M, et al. [(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors[J]. Eur J Nucl Med Mol Imaging, 2017, 44: 1945-1954. doi:  10.1007/s00259-017-3770-9
    [38] Fan M, Yuan W, Zhao W, et al. Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics[J]. IEEE J Biomed Health Inform, 2020, 24: 1632-1642. doi:  10.1109/JBHI.2019.2956351
    [39] Yang X, Wu L, Zhao K, et al. Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features[J]. Chin J Cancer Res, 2020, 32: 175-185. doi:  10.21147/j.issn.1000-9604.2020.02.05
    [40] Leithner D, Bernard-Davila B, Martinez DF, et al. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes[J]. Mol Imaging Biol, 2020, 22: 453-461. doi:  10.1007/s11307-019-01383-w
    [41] Parekh VS, Jacobs MA. Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging[J]. Breast Cancer Res Treat, 2020, 180: 407-421. doi:  10.1007/s10549-020-05533-5
    [42] Leithner D, Mayerhoefer ME, Martinez DF, et al. Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics[J]. J Clin Med, 2020, 9: 1853. doi:  10.3390/jcm9061853
    [43] Xie T, Wang Z, Zhao Q, et al. Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer[J]. Front Oncol, 2019, 9: 505. doi:  10.3389/fonc.2019.00505
    [44] Huang SY, Franc BL, Harnish RJ, et al. Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis[J]. NPJ Breast Cancer, 2018, 4: 24. doi:  10.1038/s41523-018-0078-2
    [45] Park H, Lim Y, Ko ES, et al. Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer[J]. Clin Cancer Res, 2018, 24: 4705-4714. doi:  10.1158/1078-0432.CCR-17-3783
    [46] Kim S, Kim MJ, Kim EK, et al. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer[J]. Sci Rep, 2020, 10: 3750. doi:  10.1038/s41598-020-60822-9
    [47] Koh J, Lee E, Han K, et al. Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence[J]. Sci Rep, 2020, 10: 2976. doi:  10.1038/s41598-020-59923-2
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  750
  • HTML全文浏览量:  116
  • PDF下载量:  185
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-01-05
  • 录用日期:  2021-02-23
  • 网络出版日期:  2021-11-04
  • 刊出日期:  2021-11-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！